Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Down's syndrome (DS) or trisomy 21 is the most common genetic cause of mental retardation. Development of the DS brain is associated with decreased neuronal number and abnormal neuronal differentiation, and adults with DS develop Alzheimer's disease. The cause of the neurodegenerative process in DS is unknown. Here we report that cortical neurons from fetal DS and age-matched normal brain differentiate normally in culture, but DS neurons subsequently degenerate and undergo apoptosis whereas normal neurons remain viable. Degeneration of DS neurons is prevented by treatment with free-radical scavengers or catalase. Furthermore, DS neurons exhibit a three- to fourfold increase in intracellular reactive oxygen species and elevated levels of lipid peroxidation that precede neuronal death. These results suggest that DS neurons have a defect in the metabolism of reactive oxygen species that causes neuronal apoptosis. This defect may contribute to mental retardation early in life and predispose to Alzheimer's disease in adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other biomarkers of increased oxidative damage in the brains of persons with DS and persons with DS with AD neuropathology (DS with AD) include elevated levels of HNE and PC15,42; the increases are greater in people with DS with AD62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [62]
In the citing paper
“These oxidatively modified, and likely dysfunctional, proteins include ones associated with altered glucose metabolism, mTOR signaling (including inhibited autophagy and increased insulin resistance), and the proteostasis network42,61,62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [62]
In the citing paper
“Analysis of such cortical neurons from fetuses, confirmed significantly increased levels of ROS responsible for apoptosis (Busciglio and Yanker 1995).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Busciglio and Yanker 1995
Citations
Cites
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
Bass, D. A., Parce, J. W., Dechatelet, L. R., Szejda, P., Seeds, M. C., & Thomas, M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1910 · Cited by 1,809
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
Kane, D., Sarafian, T., Anton, R., Hahn, H., Gralla, E., Valentine, J., Ord, T., & Bredesen, D. (1993) · Science · doi:10.1126/science.8235659 · Cited by 1,671
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Royall, J. A., & Ischiropoulos, H. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1222 · Cited by 1,119
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay
Cathcart, R., Schwiers, E., & Ames, B. N. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90270-1 · Cited by 852
Greenlund, L. J. S., Deckwerth, T. L., & Johnson, E. M. (1995) · Neuron · doi:10.1016/0896-6273(95)90287-2 · Cited by 742
Programmed cell death and Bcl-2 protection in very low oxygen
Jacobson, M. D., & Raff, M. C. (1995) · Nature · doi:10.1038/374814a0 · Cited by 625
Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL
Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H., & Tsujimoto, Y. (1995) · Nature · doi:10.1038/374811a0 · Cited by 611
Research works printed but not linked: 1
- Becker, L., Mito, T., Takashima, S. & Onodera, K. Prog. clin. biol. Res. 373, 133–152 (1991).
Cited by
Items 401–500 of 749
Pagano, G., Korkina, L. G., Brunk, U. T., Chessa, L., Degan, P., Principe, D. D., Kelly, F., Malorni, W., Pallardó, F. V., Pasquier, C., et al. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90084-6 · Cited by 34
c‐jun N‐terminal kinase hyperphosphorylates R406W tau at the PHF‐1 site during mitosis
Tatebayashi, Y., Planel, E., Chui, D., Sato, S., Miyasaka, T., Sahara, N., Murayama, M., Kikuchi, N., Yoshioka, K., Rivka, R., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4362fje · Cited by 33
“The cytoplasmic JNK activation may be associated with oxidative/nitration-related damage, such as lipid peroxidation (59, 60), disruption of calcium homeostasis (61), endoplasmic reticulum stress (62–64), CNS inflammation (65), and suppressed phosphatase activities (66, 67), conditions also known to be associated with…”
BackgroundLim, S.-Y., Hwang, S., Yu, J. H., Lim, J. W., & Kim, H. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600530 · Cited by 34
“Neuronal apoptosis and cognitive impairment are reported to be related to low levels of antioxidants and mitochondrial damage in DS and AD [7, 8].”
BackgroundSchmidt, M. L., Lee, V. M., Forman, M. S., Chiu, T.-L. S., & Trojanowski, J. Q. (1997) · Europe PMC (PubMed Central) · Cited by 39
A metabolomics-based approach for non-invasive diagnosis of chromosomal anomalies
Troisi, J., Sarno, L., Martinelli, P., Carlo, C. D., Landolfi, A., Scala, G., Rinaldi, M., D’Alessandro, P., Ciccone, C., & Guida, M. (2017) · Metabolomics · doi:10.1007/s11306-017-1274-z · Cited by 35
“Oxidative stress is thought to be one of the most likely causes of neurotoxicity in DS (Busciglio and Yankner 1995).”
BackgroundCocaine Downregulates the Expression of the Mitochondrial Genome in Rat Brain
Dietrich, J., Poirier, R., Aunis, D., & Zwiller, J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.042 · Cited by 35
Granese, B., Scala, I., Spatuzza, C., Valentino, A., Coletta, M., Vacca, R. A., Luca, P. D., & Andria, G. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-24 · Cited by 37
“Previous studies have shown that chronic OS is a feature of DS [35,36,71,89-92].”
BackgroundDyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death
Choi, H. K., & Chung, K. C. (2011) · Experimental Neurobiology · doi:10.5607/en.2011.20.1.35 · Cited by 36
“Besides, the susceptibility of cell death has been increased in various types of cells from DS patients (Busciglio and Yankner, 1995; Roat et al., 2007).”
Redox regulation of neuronal migration in a down syndrome model
Behar, T. N., & Colton, C. A. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00329-0 · Cited by 34
Phenotype of apoptotic lymphocytes in children with Down syndrome
Elsayed, S. M., & El‐Sayed, G. M. (2009) · Immunity & Ageing · doi:10.1186/1742-4933-6-2 · Cited by 32
“Previous authors reported increased apoptotic cells in neurons and granulocytes of DS patients [8,9].”
BackgroundAtlante, A., & Valenti, D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45050283 · Cited by 39
Necchi, D., Pinto, A., Tillhon, M., Dutto, I., Serafini, M. M., Lanni, C., Govoni, S. M., Racchi, M., & Prosperi, E. (2015) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2015.07.009 · Cited by 34
Liu, W., Zhou, H., Liu, L., Zhao, C., Deng, Y., Chen, L., Wu, L., Mandrycky, N., McNabb, C. T., Peng, Y., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.021 · Cited by 30
“Neuronal degeneration and neuronal cell death are the major contributing factors in the pathogenesis of DS (Busciglio and Yankner, 1995) and in trisomy 16 DS mice (Bambrick and Krueger, 1999; Hallam and Maroun, 1998; Stabel-Burow et al.”
Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice
Rueda, N., Vidal, V., García-Cerro, S., Narcís, J. O., Llorens-Martín, M., Corrales, A., Lantigua, S., Iglesias, M., Merino, J., Merino, R., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.05.008 · Cited by 30
Shin, J. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.12.004 · Cited by 31
Apoptosis in Down’s syndrome: lessons from studies of human and mouse models
Rueda, N., Flórez, J., & Martínez‐Cué, C. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0785-3 · Cited by 35
High‐Density Lipoprotein Aggregated by Oxidation Induces Degeneration of Neuronal Cells
Kivatinitz, S. C., Pelsman, M. A., Del C. Alonso, A., Bagatolli, L., & Quiroga, S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052102.x · Cited by 32
Péus, D., Beyerle, A., Pott, M., Meves, A., Pittelkow, M. R., Rittner, H. L., & Weyand, C. M. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00934.x · Cited by 31
Neuronal Apoptosis in Mouse Trisomy 16
Bambrick, L. L., & Krueger, B. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721769.x · Cited by 31
Targeting DNA damage in ageing: towards supercharging DNA repair
Bujarrabal-Dueso, A., Garinis, G. A., Robbins, P. D., Vijg, J., & Schumacher, B. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01212-6 · Cited by 38
Subramaniam, P., Babu, K. G., & Das, L. M. (2013) · Special Care in Dentistry · doi:10.1111/scd.12054 · Cited by 30
Base Excision Repair in Physiology and Pathology of the Central Nervous System
Bosshard, M., Markkanen, E., & van Loon, B. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131216172 · Cited by 31
“Increased XRCC1 expression might be explained by the higher levels of ROS detected in Down’s syndrome neurons [269].”
BackgroundInduction of genomic instability and activation of autophagy in artificial human aneuploid cells
Ariyoshi, K., Miura, T., Kasai, K., Fujishima, Y., Oshimura, M., & Yoshida, M. A. (2016) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2016.06.001 · Cited by 34
Quantitative comparison of radial cell columns in children with Down's syndrome and controls
Buxhoeveden, D. P., Fobbs, A. D., Roy, E., & Casanova, M. F. (2002) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.2002.00362.x · Cited by 34
Ye, W., & Blain, S. W. (2010) · Brain · doi:10.1093/brain/awq139 · Cited by 32
“…neurodegenerative disorders a major phenotype is the selective apoptosis of specific subsets of neuronal populations over years or even decades (Busciglio and Yankner, 1995; Offen et al., 2000; Jimenez del Rio and Velez-Pardo, 2001; Raina et al., 2001; Becker and Bonni, 2004; Jellinger, 2006;…”
BackgroundMikami, M., Yamazaki, M., & Yui, S. (1998) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1998.tb02273.x · Cited by 30
Hasaart, K., Manders, F., van der Hoorn, M., Verheul, M., Poplonski, T., Kuijk, E., Lopes, S. M. C. D. S., & van Boxtel, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-69822-1 · Cited by 29
Labudová, O., Cairns, N. J., Koeck, T., Kitzmüller, E., Rink, H., & Lübec, G. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00030-2 · Cited by 29
Hallam, D. M., Capps, N. L., Travelstead, A. L., Brewer, G. J., & Maroun, L. E. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00289-7 · Cited by 30
Mechanisms of neuronal death in Down’s syndrome
Nagy, Z. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_15 · Cited by 33
Trisomy 21 results in modest impacts on mitochondrial function and central carbon metabolism
Anderson, C. C., Marentette, J., Prutton, K. M., Rauniyar, A. K., Reisz, J. A., D’Alessandro, A., Maclean, K. N., Saba, L. M., & Roede, J. R. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.003 · Cited by 28
Oxidative Stress in Down and Williams-Beuren Syndromes: An Overview
Ferrari, M., & Stagi, S. (2021) · Molecules · doi:10.3390/molecules26113139 · Cited by 29
“Altered mitochondrial activity and oxidative stress have long been associated with DS [16,21,22].”
BackgroundNeurological impairment in fetal mouse brain by drinking water disinfectant byproducts
Ahmed, A. E., Campbell, G. A., & Jacob, S. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2004.11.001 · Cited by 27
Deleterious network hypothesis of aging
Ying, W. (1997) · Medical Hypotheses · doi:10.1016/s0306-9877(97)90281-4 · Cited by 30
Human neural stem cells: a new tool for studying cortical development in Down's syndrome
Bhattacharyya, A., & Svendsen, C. N. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00025.x · Cited by 27
“These DS neurons were rendered more vulnerable to apoptosis by the accumulation of intracellular reactive oxygen species (Busciglio & Yankner 1995).”
BackgroundOxidative stress as a necessary factor in room temperature-induced apoptosis of HL-60 cells
Shimura, M., Osawa, Y., Yuo, A., Hatake, K., Takaku, F., & Ishizaka, Y. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.87 · Cited by 27
“It has been reported that ROS production is related to a variety of pathological conditions such as neurodegenerative diseases [44, 45] and ischemia [31].”
BackgroundApoptosis in Neurodegenerative Diseases
Nishimoto, I., Okamoto, T., Giambarella, U., & Iwatsubo, T. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61064-9 · Cited by 27
Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome
Ruparelia, A., Pearn, M. L., & Mobley, W. C. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.05.002 · Cited by 28
Martini, A. C., Gross, T. J., Head, E., & Mapstone, M. E. (2022) · Neuron · doi:10.1016/j.neuron.2022.04.001 · Cited by 28
Pendota, S. C., Ndhlala, A. R., Aremu, A. O., Aderogba, M. A., & Staden, J. V. (2014) · South African Journal of Botany · doi:10.1016/j.sajb.2014.03.012 · Cited by 27
Unique clinical and biological features of leukemia in Down syndrome children
Xavier, A. C., Ge, Y., & Taub, J. W. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.14 · Cited by 26
Necrosis and apoptosis in lymphoma cell lines exposed to eicosapentaenoic acid and antioxidants
Heimli, H., Finstad, H. S., & Drevon, C. A. (2001) · Lipids · doi:10.1007/s11745-001-0765-x · Cited by 27
Mechanisms of neuronal cell injury/death and targets for drug intervention
Boxer, P. A., & Bigge, C. F. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01045-3 · Cited by 27
Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease
García, O., & Aguilar, L. F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.987212 · Cited by 26
Down's syndrome astrocytes have greater antioxidant capacity than euploid astrocytes
Sebastià, J., Cristòfol, R., Pertusa, M., Vílchez, D., Torán, N., Barambio, S., Rodríguez‐Farré, E., & Sanfeliu, C. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03686.x · Cited by 26
“In vitro, human DS astrocytes develop normally (Busciglio & Yankner, 1995), but some deleterious changes have been reported in these cells (Busciglio et al., 2002) and in astrocytes from DS animal models (Nelson et al., 1997; Bambrick et al., 2003).”
BackgroundZhou, G.-J., Wang, W., Xie, X., Qin, M., Kuai, B., & Tong-shui, Z. (2014) · Molecules · doi:10.3390/molecules19067207 · Cited by 25
“ROS formation and accumulation is believed to be one of the important causes of many diseases and aging [31–33].”
Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome
Lee, S. E., Duran-Martinez, M., Khantsis, S., Bianchi, D. W., & Guedj, F. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.10.001 · Cited by 26
“—In vitro, primary cortical neurons and astrocytes derived from fetuses with DS showed increased reactive oxygen species (ROS) and apoptosis [61], increased accumulation of Aβ intracellularly, and deficits in amyloidogenic processing [62].”
BackgroundOverexpression of transcription factor BACH1 in fetal Down Syndrome brain
Ferrando-Miguel, R., Cheon, M. S., Yang, J., & Lübec, G. (2003) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6721-2_17 · Cited by 27
Motonaga, K., Itoh, M., Hirayama, A., Hirano, S., Becker, L. E., Goto, Y., & Takashima, S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02535-5 · Cited by 25
Sureda, F. X., Gabriel, C., Comas, J., Pallàs, M., Escubedo, E., Camarasa, J., & Camins, A. (1999) · Brain Research Protocols · doi:10.1016/s1385-299x(99)00030-6 · Cited by 25
Aerobic Exercise Reduced Oxidative Stress in Saliva of Persons With Down Syndrome
Contreras, J. C. Z., Marquina, R. A., Sulbarán, N., Rodriguez-Malaver, A. J., & Reyes, R. (2009) · Research in Sports Medicine · doi:10.1080/15438620903120843 · Cited by 24
“Oxidative stress (OS) level is higher in individuals with DS ( Busciglio and Yankner 1995 ; Carratelli et al.”
BackgroundAlteration of caspases and other apoptosis regulatory proteins in Down syndrome
Gulesserian, T., Engidawork, E., Yoo, B. C., Cairns, N. J., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_13 · Cited by 28
Desai, A. R., Branco, R. G., Comitis, G., Maiya, S. S., Vyas, D., Silva, P. V., Sethia, B., Slavík, Z., & LaRovere, J. M. (2013) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000004 · Cited by 25
“Dysplastic atrioventricular valve 9 (13) 4 (10) 0.”
BackgroundAge-related changes in apoptosis in rat hippocampus induced by oxidative stress
Uysal, N., Tuğyan, K., Aksu, İ., Özbal, S., Ozdemir, D., Dayı, A., Gönenç, S., & Açıkgöz, O. (2011) · Biotechnic & Histochemistry · doi:10.3109/10520295.2011.556665 · Cited by 24
“, the cortical neurons of human embryos affected by Down syndrome are associated with increased generation of ROS compared to normal neurons (Busciglio and Yankner 1995).”
BackgroundAging: Minimizing Free Radical Damage
Harman, D. (1999) · Rejuvenation Research · doi:10.1089/rej.1.1999.2.15 · Cited by 25
Qin, S., Ding, J., Takano, T., & Yamamura, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1079 · Cited by 24
Haney, M. J., Zhao, Y., Fay, J. M., Hwang, D., Wang, M., Wang, H., Li, Z., Lee, Y. Z., Karuppan, M. K. M., El‐Hage, N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68874-7 · Cited by 24
RetractedSchuchmann, S., & Heinemann, U. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741205.x · Cited by 23
RetractedAltered astrocyte calcium homeostasis and proliferation in theTs65Dn mouse, a model of Down syndrome
Bambrick, L. L., Yarowsky, P. J., & Krueger, B. K. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10630 · Cited by 23
Paré, B., & Gros‐Louis, F. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0004 · Cited by 26
“…cellular stress, which has been previously shown to be linked to the development of neurological diseases such as Alzheimer’s disease, Parkinson’s disease, Down syndrome, and ALS (Dipasquale et al., 1991; Loo et al., 1993; Hartley et al., 1994; Busciglio and Yankner, 1995; Nishio et al., 2000).”
BackgroundYamashita, S., Kanno, S., Nakagawa, K., Kinoshita, M., & Miyazawa, T. (2015) · RSC Advances · doi:10.1039/c5ra00632e · Cited by 22
Down Syndrome, Obesity, Alzheimer’s Disease, and Cancer: A Brief Review and Hypothesis
Nixon, D. W. (2018) · Brain Sciences · doi:10.3390/brainsci8040053 · Cited by 22
“Increased neuronal apoptosis from a defect in metabolism of reactive oxygen species has also been suggested in DS [68].”
BackgroundMensah, A. A., Mulligan, C., Linehan, J., Ruf, S., O’Doherty, A., Grygalewicz, B., SHIPLEY, J. M., Groet, J., Tybulewicz, V. L. J., Fisher, E., et al. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-131 · Cited by 26
“Also, DS foetal neural cells showed a reduced propensity for proliferation and survival in vitro compared to euploid controls [8].”
BackgroundBeni, S. M., Tsenter, J., Alexandrovich, A. G., Galron-Krool, N., Barzilai, A., Kohen, R., Grigoriadis, N., Simeonidou, C., & Shohami, E. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600209 · Cited by 22
“Hence, SOD1 may specifically confer protection in ischemic–reperfusion injuries and in paradigms of O2 K -mediated neural damage (Fujimura et al, 2000; Lewen et al, 2001; Yoshida et al, 2000) while aggravating damage in H2O2/OH K -mediated pathologies (Busciglio and Yanker, 1995; de Haan et al, 1996; Peled-Kamar et al…”
BackgroundMuto, Y., & Sato, K. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00696-4 · Cited by 24
Stabel, J., Kleu, A., Schuchmann, S., & Heinemann, U. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00480-0 · Cited by 22
Fang-Kircher, S. G., Labudová, O., Kitzmüller, E., Rink, H., Cairns, N. J., & Lübec, G. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00107-1 · Cited by 22
Progress in mimicking brain microenvironments to understand and treat neurological disorders
Ngo, M. T., & Harley, B. A. C. (2021) · APL Bioengineering · doi:10.1063/5.0043338 · Cited by 22
The Role of Oxidative Stress in Trisomy 21 Phenotype
Buczyńska, A., Sidorkiewicz, I., Kretowski, A. J., & Zbucka-Krętowska, M. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01417-6 · Cited by 21
“This defect is caused by reduced acquisition of a neuronal phenotype and an increase in the acquisition of an astrocytic phenotype by neural progenitor cells (J. Lu, Sheen, and Shee 2013; Busciglio and Yankner 1995) .”
BackgroundERCC1-deficient cells and mice are hypersensitive to lipid peroxidation
Czerwińska, J., Nowak, M., Wojtczak, P., Dziuban-Lech, D., Cieśla, J., Kołata, D., Gajewska, B., Barańczyk‐Kuźma, A., Robinson, A. R., Shane, H. L., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.088 · Cited by 23
“LPO is also elevated in brain matter of patients with neurodegeneration and other age-related diseases [4,5].”
Modeling Down syndrome in cells: From stem cells to organoids
Gough, G., O’Brien, N. L., Alić, I., Goh, P. A., Yeap, Y. J., Groet, J., Nižetić, D., & Murray, A. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.003 · Cited by 21
Modulation of Lipid Metabolism by Centella Asiatica in Oxidative Stress Rats
Hussin, M., Hamid, A. A., Mohamad, S., Saari, N., Bakar, F., & Dek, S. P. (2009) · Journal of Food Science · doi:10.1111/j.1750-3841.2009.01045.x · Cited by 21
Seidl, R., Cairns, N. J., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_20 · Cited by 22
Antonucci, A. T., Baldassarre, A. D., Giacomo, F. D., Stuppia, L., & Palka, G. (1997) · Ultrastructural Pathology · doi:10.3109/01913129709021944 · Cited by 21
Egensperger, R., Weggen, S., Ida, N., Multhaup, G., Schnabel, R., Beyreuther, K. T., & Bayer, T. A. (1999) · Acta Neuropathologica · doi:10.1007/s004010050963 · Cited by 21
“In addition, neurons in trisomy 21 exhibit a threeto fourfold increase in intracellular reactive oxygen species, which may predispose to plaque formation [ 6 ].”
BackgroundThe Shape of Mitochondrial Dysfunction in Down Syndrome
Zamponi, E., & Helguera, P. R. (2019) · Developmental Neurobiology · doi:10.1002/dneu.22673 · Cited by 20
“DYSFUNCTION IN DS AND AGING A pivotal report from Busciglio and Yankner (1995) described the premature degeneration and cell death in primary cortical DS neurons in‐vitro.”
BackgroundNeural Development and Lifelong Plasticity
Nelson, C. A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511975394.003 · Cited by 22
Yamada, S., Hongo, T., Okada, S., Watanabe, C., Fujii, Y., Hori, H., Yazaki, M., Hanada, R., & Horikoshi, Y. (2001) · International Journal of Hematology · doi:10.1007/bf02982087 · Cited by 20
“These results suggest the presence of leukemogenic genes and several tumor-suppressor genes on chromosome 21. In vitro studies have suggested an increased oxidative stress by generation of free radicals in DS, and protection from malignant transformation may be secured by increased spontaneous apoptosis [ 26 ,27].”
BackgroundReactive Oxygen Species and Apoptosis
Bauer, G., Dormann, S., Engelmann, I., Schulz, A., & Sarán, M. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57075-9_11 · Cited by 32
The role of apoptosis in neurodegenerative diseases
Hajimohammadreza, I., & Treherne, J. M. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8861-5_3 · Cited by 22
Lucius, R., & Sievers, J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00170-8 · Cited by 20
Kadota, M., Shirayoshi, Y., & Oshimura, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02686-4 · Cited by 21
Reduced aldehyde dehydrogenase levels in the brain of patients with Down Syndrome
Lübec, G., Labudová, O., Cairns, N. J., Berndt, P., Langen, H., & Fountoulakis, M. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_2 · Cited by 22
Pathway and mechanism of oxidative stress in Alzheimer's disease
Cai, Z., & Yan, Y. (2007) · 中国人民解放军军医大学学报:英文版 · doi:10.1016/s1000-1948(07)60064-1 · Cited by 19
Engidawork, E., Balic, N., Juranville, J., Fountoulakis, M., Dierssen, M., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_12 · Cited by 21
Down Syndrome, Ageing and Epigenetics
Gensous, N., Franceschi, C., Salvioli, S., Garagnani, P., & Bacalini, M. G. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_7 · Cited by 23
Velez‐Pardo, C., Jiménez-Del-Río, M., & Lopera, F. J. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00189-x · Cited by 19
Tolun, A. A., Scarbrough, P. M., Zhang, H., McKillop, J.-A., Wang, F. M., Kishnani, P. S., Millington, D. S., Young, S. P., & Il’yasova, D. (2012) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.09.005 · Cited by 18
“were true, the antioxidant treatments would then hold the most promise to ameliorate DSassociated morbidities (4).”
BackgroundResultInsights on Localized and Systemic Delivery of Redox‐Based Therapeutics
Buglak, N., Batrakova, E. V., Mota, R. I., & Bahnson, E. M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2468457 · Cited by 20
Esmat, A., Ghoneim, A. I., El‐Demerdash, E., Khalifa, A. E., & Abdel‐Naim, A. B. (2011) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2011.11.004 · Cited by 18
Mitochondrial amyloid-beta peptide: Pathogenesis or late-phase development?
Yan, S. D., Xiong, W., & Stern, D. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9205 · Cited by 19
“Oxygen-free radical scavengers had the capacity to prevent such apoptosis [46].”
BackgroundIncreased heart rate variability in mice overexpressing the Cu/Zn superoxide dismutase
Thireau, J., Poisson, D., Zhang, B. L., Gillet, L., LePecheur, M., Andres, C. R., London, J., & Babuty, D. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.020 · Cited by 18
Cu,Zn-Superoxide Dismutase Gene Dosage and Cell Resistance to Oxidative Stress: A Review
Peskin, A. V. (1997) · Bioscience Reports · doi:10.1023/a:1027343519591 · Cited by 19
Stewart, C. A., Hyam, K., Wallis, G. L., Sang, H., Robinson, K. A., Floyd, R. A., Kotake, Y., & Hensley, K. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1159 · Cited by 18
Cell models for Down syndrome-Alzheimer’s disease research
Wu, Y., West, N. R., Bhattacharyya, A., & Wiseman, F. K. (2022) · Neuronal Signaling · doi:10.1042/ns20210054 · Cited by 17
Shields, N., Downs, J. A., de Haan, J. B., Taylor, N. F., Torr, J. J., Fernhall, B., Kingsley, M., Mnatzaganian, G., & Leonard, H. (2017) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2017.10.015 · Cited by 17
Use of Human Central Nervous System Cell Cultures in Neurotoxicity Testing
Sanfeliu, C., Cristòfol, R. M., Torán, N., Rodríguez-Farré, E., & Kim, S. U. (1999) · Toxicology in Vitro · doi:10.1016/s0887-2333(99)00065-x · Cited by 19
Boutennoun, H., Boussouf, L., Kebieche, M., Al-Qaoud, K. M., & Madani, K. (2017) · South African Journal of Botany · doi:10.1016/j.sajb.2017.06.004 · Cited by 21
Down’s syndrome and Alzheimer’s disease: two sides of the same coin
Potter, H. (2007) · Future Neurology · doi:10.2217/14796708.3.1.29 · Cited by 21
“Indeed, cortical neurons from DS fetuses undergo spontaneous apoptosis in vitro [81].”
BackgroundHallam, D. M., & Maroun, L. E. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00541-2 · Cited by 17
Metadata
- Authors
- Busciglio, J., & Yankner, B. A.
- Affiliations
- Boston Children's Hospital (US)
- Venue
- Nature
- Published
- 1995-12
- Volume
- 378
- Issue
- 6559
- Pages
- 776-779
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1992689843
- Cited by
- 741
- References
- 26
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 6 · 2023: 16 · 2022: 13 · 2021: 13 · 2020: 16 · 2019: 19 · 2018: 16 · 2017: 15 · 2016: 21 · 2015: 21 · 2014: 25 · 2013: 30 · 2012: 32
- FWCI
- 57.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Down syndrome, neuronal apoptosis, reactive oxygen species, lipid peroxidation, cortical neurons, neurodegeneration, radical scavengers, catalase, Alzheimer's disease, intellectual disability, oxidative stress
- MeSH terms
- Alzheimer Disease, Antioxidants, Cell Differentiation, Cells, Cultured, Cerebral Cortex, Cycloheximide, Dactinomycin, Down Syndrome, Fluoresceins, Humans, Nerve Degeneration, Neurons, Lipid Peroxidation, Free Radical Scavengers, Apoptosis, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.